{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:47:13Z","timestamp":1782251233485,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.vaccine.2026.128609","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:49:26Z","timestamp":1776883766000},"page":"128609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Understanding adjuvant supply chains for new TB and malaria vaccines"],"prefix":"10.1016","volume":"82","author":[{"given":"Dzintars","family":"Gotham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Frick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128609_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-023-02992-7","article-title":"New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent\/adult vaccination with M72\/AS01E and BCG-revaccination","volume":"21","author":"Clark","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2026.128609_bb0010","author":"Malaria Vaccines"},{"key":"10.1016\/j.vaccine.2026.128609_bb0015","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-025-03453-x","article-title":"Advancements in saponin-based vaccine adjuvants","author":"Cao","year":"2025","journal-title":"Med Chem Res"},{"key":"10.1016\/j.vaccine.2026.128609_bb0020","article-title":"From forest to factory: tracing the supply chains for two modern adjuvants of global health importance \u2014 QS-21 and MPL. New York:","author":"Gotham","year":"2025","journal-title":"Treatment Action Group;"},{"key":"10.1016\/j.vaccine.2026.128609_bb0025","author":"CDC"},{"key":"10.1016\/j.vaccine.2026.128609_bb0030","doi-asserted-by":"crossref","first-page":"1726153","DOI":"10.3389\/fpubh.2025.1726153","article-title":"Chaves Gabriela Costa Tb vaccine development: monitoring international patent filings to anticipate access challenges","volume":"13","author":"Pignataro Maria","year":"2026","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2026.128609_bb0035","article-title":"How a big pharma company stalled a potentially lifesaving vaccine in pursuit of bigger profits","author":"Barry-Jester","year":"2023","journal-title":"ProPublica"},{"key":"10.1016\/j.vaccine.2026.128609_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14760584.2020.1745636","article-title":"Army liposome formulation (ALF) family of vaccine adjuvants","volume":"19","author":"Alving","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128609_bb0045","author":"World-First"},{"key":"10.1016\/j.vaccine.2026.128609_bb0050","author":"Jaecklin"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:53:46Z","timestamp":1782248026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26004172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":10,"alternative-id":["S0264410X26004172"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128609","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding adjuvant supply chains for new TB and malaria vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128609"}}